Is a Liver Biopsy Necessary? Investigation of a Suspected Hepatocellular Carcinoma: A Pictorial Essay of Hepatocellular Carcinoma and the Revised American Association for the Study of Liver Disease Criteria

Kim T.K. Jang H. Wilson S.R. Imaging diagnosis of hepatocellular carcinoma with differentiation from other pathology Clin Liver Dis 2005; 9:253–279.

Pocobelli G. Cook L.S. Brant R. Hepatocellular carcinoma incidence trends in Canada: analysis by birth cohort and period of diagnosis Liver Int 2008; 28:1272–1279.

Abrams P. Marsh J.W. Current approach to hepatocellular carcinoma Surg Clin N Am 2010; 90:803–816.

Beasley R.P. Hwang L.Y. Lin C.C. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan Lancet 1981; II:1129–1133.

Terjunga B. Lemnitzera I. Ludwig Dumoulina F. Bleeding complications after percutaneous liver biopsy Digestion 2003; 67:138–145.

Myers R.P. Fong A. Shaheen A.A. Utilization rates, complications and costs of percutaneous liver biopsy: a population-based study including 4275 biopsies Liver Int 2008; 28:705–712.

McGill D.B. Rakela J. Zinsmeister A.R. A 21-year experience with major hemorrhage after percutaneous liver biopsy Gastroenterology 1990; 99:1396–1400.

Piccinino F. Sagnelli E. Pasquale G. Complications following percutaneous liver biopsy. A multicentre retrospective study on 68 276 biopsies J Hepatol 1986; 2:165–173.

Huang J.F. Hsieh M.Y. Dai C.Y. The incidence and risks of liver biopsy in non-cirrhotic patients: an evaluation of 3806 biopsies Gut 2007; 56:736–737.

Dumortier J. Lombard-Bohas C. Valette P.J. Needle tract recurrence of hepatocellular carcinoma after liver transplantation Gut 47 2000 301

Huffman GR, Uzar A, Gorgulu S, et al. Preoperative needle biopsy and long-term outcome of patients undergoing resection for hepatocellular carcinoma. Presented at the 48th Annual Meeting of the American Association for the Study of Liver Diseases. November 7-11, 1997; Chicago, IL.

Willatt J.M. Hussain H.K. Adusumilli S. MR imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies Radiology 2008; 247:311–330.

Bruix J. Sherman M. Management of hepatocellular carcinoma: an update Hepatology 2011; 53:1020–1022.

Hu K.Q. Kyulo N.L. Lim N. Clinical significance of elevated alpha-fetoprotein (AFP) in patients with chronic hepatitis C, but not hepatocellular carcinoma Am J Gastroenterol 2004; 99:860–865.

Di Biscelglie A.M. Hoofnagle J.H. Elevations in alpha-fetoprotein levels in patients with chronic hepatitis B Cancer 1989; 64:3117–3120.

Outwater E.K. Imaging of the liver for hepatocellular cancer Cancer Control 2010; 17:72–82.

Saar B. Kellner-Weldon F. Radiological diagnosis of hepatocellular carcinoma Liver Int 2008; 28:189–199.

Wilson S.R. Burns P.N. Microbubble-enhanced US in body imaging: what role? Radiology 2010; 257:24–39.

Mitsuzaki K. Yamashita Y. Ogata I. Multiple-phase helical CT of the liver for detecting small hepatomas in patients with liver cirrhosis: contrast-injection protocol and optimal timing Am J Roentgenol 1996; 167:753–757.

Yamashita Y. Mitsuzaki K. Yi T. Small hepatocellular carcinoma in patients with chronic liver damage: prospective comparison of detection with dynamic MR imaging and helical CT of the whole liver Radiology 1996; 200:79–84.

Krinksy G.A. Israel G. Nondysplastic nodules that are hyperintense on T1 weighted gradient-echo MR Imaging AJR Am J Roentenol 2003; 180:1023–1027.

Hahn P.F. Saini S. Liver specific MR imaging contrast agents Radiol Clin North Am 1998; 36:287–297.

Manfredi R. Maresca G. Baron R.L. Delayed MR imaging of hepatocellular carcinoma enhanced by gadobenate dimeglumine (GD-BOPTA) J Magn Reson Imaging 1999; 9:704–710.

WHO. Viral cancers: hepatitis C. Available at: www.WHO.INT/vaccine_research/diseases/viral_cancers/EN/index_2.HTML. Accessed April 4, 2008.

Lai C.I. Ratziu V. Yuen M.F. Lancet 2003; 362:2089–2094.

Sherman M. Shafran S. Burak K. Management of chronic hepatitis: Consensus Guidelines Can J Gastroenterol 21 Suppl C 2007 5C–24C.

ElSaadany S. Tepper M. Mao Y. An epidemiologic study of HCC in Canada Can J Pub Health 2002; 93:443–446.